超声成像用于检测浸润性乳腺癌腋窝淋巴结清扫术后II级和III级腋窝淋巴结转移
该回顾性研究分析了2005年1月至2017年12月在一家癌症中心经超声检出II级或III级腋窝淋巴结的401例浸润性乳腺癌腋窝淋巴结清扫术后病例,比较超声与触诊对II级和III级腋窝淋巴结转移的诊断价值并分析预测转移复发的超声特征。最终经病理确诊55例腋窝转移(14%),超声的敏感度、特异度和AUC分别为92.7%、93.9%和0.933,触诊分别为49.1%、91.3%和0.702(P < .001)。结论认为超声有助于腋窝淋巴结清扫术后II级和III级腋窝淋巴结的随访,并能比触诊更早发现癌症复发。
要点
- 超声诊断II/III级腋窝淋巴结转移的敏感度92.7%、特异度93.9%、AUC 0.933,均优于触诊。
- 淋巴结长径或短径增加大于2 mm、Solbiati指数小于1.5及出现新可疑病灶提示转移复发。
- 超声可在随访中比触诊更早检出腋窝淋巴结复发。
核心结论
- 腋窝超声有助于浸润性乳腺癌腋窝淋巴结清扫术后II级和III级腋窝淋巴结的随访,并能比触诊更早发现癌症复发。
研究设计与样本
- 回顾性分析2005年1月至2017年12月在一家癌症中心经超声检出II级或III级腋窝淋巴结的病例,共纳入401例,根据超声表现分为潜在恶性组(全部行活检)和随访组(随访至少2年,出现可疑超声特征时行活检),并与触诊比较。
关键影像表现/征象
- 淋巴结长径或短径增加大于2 mm为淋巴结转移的显著预测因素(P = .013)。
- Solbiati指数值小于1.5为淋巴结转移的显著预测因素(P = .006)。
- 其他区域出现新可疑病灶为淋巴结转移的显著预测因素(P = .015)。
- 另一超声特征预测淋巴结转移的P值为.036。
诊断标准与关键数值
- 超声诊断II级和III级腋窝淋巴结转移的敏感度92.7%、特异度93.9%、AUC 0.933。
- 触诊诊断II级和III级腋窝淋巴结转移的敏感度49.1%、特异度91.3%、AUC 0.702。
- 超声与触诊的AUC比较P < .001。
- 最终经病理确诊55例腋窝转移,占14%。
临床应用与阅片要点
- 对浸润性乳腺癌腋窝淋巴结清扫术后患者,可运用超声随访II级和III级腋窝淋巴结,其诊断价值优于触诊。
- 阅片时关注淋巴结长径或短径增加大于2 mm、Solbiati指数小于1.5及其他区域新可疑病灶等提示转移复发的超声特征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The diagnostic value of axillary ultrasound (US) for level II and III axillary lymph node metastasis after axillary lymph node dissection for invasive breast cancer is currently not clear. The objectives of this study were to retrospectively analyze the diagnostic value of axillar US for level II and III axillary lymph node metastasis and compare it with palpation and to analyze the US features of level II and III axillary lymph nodes that are predictive of metastatic recurrence during follow-up.
METHODS: Cases with level II or III axillary lymph nodes detected by US between January 2005 and December 2017 at a cancer center were divided into 2 groups according to a retrospective analysis of US findings: potential malignancy group and follow-up group. Biopsy was performed in all patients in the potential malignancy group. In the follow-up group, the patients were followed for at least 2 years, and biopsy was performed if suspicious US features were detected.
RESULTS: The 401 enrolled cases were followed by axillary US and physical examination (PE) for comparison. Finally, 55 axillary metastases were pathologically confirmed (14%). The sensitivity, specificity, and area under the receiver operating characteristic curve for axillary US were 92.7%, 93.9%, and 0.933, respectively, and the corresponding values for PE were 49.1%, 91.3%, and 0.702 (P < .001). An increase in the major or minor axis diameter of the lymph nodes of greater than 2 mm, a Solbiati index value of less than 1.5, and the presence of new suspicious lesions in other regions were significant predictors of lymph node metastasis based on the US findings (P = .013, .006, .015, and .036).
CONCLUSIONS: Axillary is helpful in the follow-up of level II and III axillary lymph nodes after axillary lymph node dissection for invasive breast cancer and can detect cancer recurrence earlier than PE.
引用
- Lin X, An X, Xiang H, et al. Ultrasound Imaging for Detecting Metastasis to Level II and III Axillary Lymph Nodes after Axillary Lymph Node Dissection for Invasive Breast Cancer. J Ultrasound Med. 2019. PMID: 30912182. doi:10.1002/jum.14998
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。